The short answer
Magnesium citrate does not have an established routine separation requirement with inhaled levalbuterol. Laxative use and electrolyte problems need a separate review.
What this answer covers
Oral magnesium citrate supplements or laxatives; not intravenous magnesium sulfate or a different oral magnesium salt.
- Supplement or preparation
- Magnesium citrate
- Medication ingredient
- levalbuterol
Dose and purpose change the question
A routine supplement and a bowel-cleansing regimen have different fluid and electrolyte effects. Tell the clinician whether magnesium citrate is being used for nutrition, constipation or bowel preparation.
The available study has limits
A study of a specific picosulfate and magnesium citrate bowel preparation found no clinically meaningful cardiac conduction effects in selected patients. It did not establish safety for levalbuterol users with kidney, heart or electrolyte problems.
No established absorption gap
Levalbuterol is inhaled, and the reviewed evidence does not show magnesium citrate blocking its absorption in the gut. Follow the prescribed bowel plan rather than inventing a separation schedule.
When review matters
Contact the clinician about significant diarrhea, dehydration, muscle weakness, palpitations or fainting. Levalbuterol can lower blood potassium temporarily, so abnormal results should be assessed in context rather than treated with an automatic supplement.
Evidence and practical considerations
Timing & monitoring
The current blanket timing/avoidance claim is unsupported. Conditional concern is electrolyte disturbance from substantial laxative use or dehydration alongside levalbuterol cardiovascular/hypokalemia effects, not proven impaired inhaled-drug absorption.
- Exact scope
- Oral magnesium citrate supplements or laxatives; not intravenous magnesium sulfate or a different oral magnesium salt. with Exact levalbuterol hydrochloride nebulized inhalation solution and tartrate HFA inhalation aerosol. Exact RxNorm IN237159, R-enantiomer of albuterol. Hydrochloride nebulizer and tartrate HFA labels are distinct; racemic albuterol is a comparator, not an interchangeable exact drug.
- Medication form and route
- inhalation
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact pair trial; a selected bowel-preparation study used sodium picosulfate with magnesium citrate and is not isolated citrate or high-risk patient evidence.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed levalbuterol.
Exact product cardiovascular effects, possible ECG changes, tremor, transient hypokalemia and cautions with additional adrenergic drugs.
How this applies: Exact RxNorm IN237159, R-enantiomer of albuterol. Hydrochloride nebulizer and tartrate HFA labels are distinct; racemic albuterol is a comparator, not an interchangeable exact drug.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed levalbuterol.
Exact product cardiovascular effects, possible ECG changes, tremor, transient hypokalemia and cautions with additional adrenergic drugs.
How this applies: Exact RxNorm IN237159, R-enantiomer of albuterol. Hydrochloride nebulizer and tartrate HFA labels are distinct; racemic albuterol is a comparator, not an interchangeable exact drug.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 598 selected colonoscopy patients from two trials.
Transient modest magnesium rises; no clinically significant cardiac-conduction effect attributed to elevated magnesium.
How this applies: Only the studied preparation, route and measured endpoints apply; no untested respiratory medication transfer.
Combination bowel preparation, not isolated supplement or levalbuterol co-use. Important renal, electrolyte and cardiac exclusions limit high-risk generalization.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: 2670103e4b57bcdc
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.